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Abstract
Purpose The aim of this study was to assess the ability of
real-time breath-hold-triggered myocardial perfusion imaging
(MPI) using a novel cadmium-zinc-telluride (CZT) gamma
camera to discriminate artefacts from true perfusion defects.
Methods A group of 40 patients underwent a 1-day 99mTc-
tetrofosmin pharmacological stress/rest imaging protocol on
a conventional dual detector SPECT gamma camera with
and without attenuation correction (AC), immediately
followed by scanning on an ultrafast CZT camera with
and without real-time breath-hold triggering (instead of
AC) by intermittent scanning confined to breath-hold at
deep inspiration (using list mode acquisition). We studied
the use of breath-hold triggering on the CZT camera and its
ability to discriminate artefacts from true perfusion defects
using AC SPECT MPI as the reference standard. Myocar-
dial tracer uptake (percent of maximum) from CZT was
compared to AC SPECT MPI by intraclass correlation and
by calculating Bland-Altman limits of agreement.
Results AC of SPECT MPI identified 19 apparent perfusion
defects as artefacts. Of these, 13 were correctly identified and
4 were partially unmasked (decrease in extent and/or severity)
by breath-hold triggering of the CZT scan. All perfusion
defects verified by SPECT MPI with AC were appropriately
documented by CZTwith and without breath-hold triggering.
This was supported by the quantitative analysis, as the
correlation (r) of myocardial tracer uptake between CZT
and AC SPECT improved significantly from 0.81 to 0.90
(p<0.001) when applying breath-hold triggering. Similarly,
Bland-Altman limits of agreement were narrower for CZT
scans with breath-hold triggering.
Conclusion This novel CZT camera allows real-time breath-
hold triggering as a potential alternative to AC to assist in the
discrimination of artefacts from true perfusion defects.
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Introduction
Myocardial perfusion imaging (MPI) plays a key role in the
noninvasive assessment of cardiac disease including predic-
tion of prognosis and choice of adequate treatment strategies
in patients with known or suspected ischaemic coronary artery
disease (CAD) [1]. However, although MPI is a valuable
clinical tool, it is nevertheless subject to a variety of artefacts
and potential pitfalls, which may affect its clinical utility [2].
Common sources of artefacts in MPI studies are attenuation
of photons by the patient’s body as well as prominent
subdiaphragmatic gastrointestinal activity which typically
interferes with the adjacent inferior myocardial wall and may
either lead to increased activity (due to spill-over) or to
apparently decreased activity (caused by hot spots).
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Several strategies to address these problems and to
discriminate artefacts from perfusion defects have been
proposed, such as scanning in the prone position [3],
integrating findings from gated SPECT [4], and attenuation
correction (AC) using line sources [5] or low-dose CT [6].
As an alternative for improving SPECT image quality,
respiratory gating has been suggested [7–11], but has
remained challenging due to the step-and-shoot acquisition
mode with SPECT gamma cameras with rotating detectors.
The introduction of a novel generation of gamma cameras
using cadmium-zinc-telluride (CZT) detectors may at least in
part help to overcome these drawbacks and limitations. The
miniaturized CZT detectors and a multipinhole design enables
alignment of the detectors around the patient, thus covering
the entire heart at all times and rendering camera rotation
around the patient unnecessary thus allowing a more than
fivefold shortening of the scan time [12, 13]. In addition, this
enables intermittent scanning which, in combination with
list-mode acquisition, allows breath-hold triggering.
Thus, the aim of the present study was to assess the
ability of real-time breath-hold triggering of CZT scanning
to discriminate MPI artefacts from true perfusion defects
using AC of SPECT MPI as the reference standard.
Materials and methods
Study protocol and image acquisition
A group of 40 patients referred for SPECTMPI for evaluation
of CAD underwent a 1-day 99mTc-tetrofosmin stress/rest MPI
protocol as suggested by the guidelines of the European
Association of Nuclear Medicine [14]. Scanning for stress
and rest was performed first on a conventional dual detector
SPECT gamma camera (Ventri, GE Healthcare). The scan
duration was 14 min and 52 s for both stress and rest. Each
scan was repeated within minutes on an ultrafast CZT
camera (Discovery 530 NMc, GE Healthcare) once with
regular acquisition, i.e. with normal breathing, and a second
time with real-time breath-hold triggering. Therefore,
patients were repeatedly told to perform a breath-hold at a
deep inspiration level while scanning was manually initiated
after end inspiration to ensure confinement of the acquisition
to breath-hold at deep inspiration. After scanning at breath-
hold for a time (10–20 s) that had been individually
determined according to the patient’s ability, acquisition
was manually interrupted and the patient was allowed to
breathe normally before continuing the scan. This sequence
was repeated until an overall scan duration of 3 min for
stress and 2 min for rest was reached, as previously
established for this camera [12, 13].
Pharmacological stress was induced by standard adeno-
sine or dobutamine infusion [14]. 99mTc-tetrofosmin was
injected after 3 min of induced stress. The injection was
followed by a wait of 90 min before image acquisition on
both cameras. Rest MPI was performed thereafter with the
identical acquisition protocol after injection of a three times
higher dose of 99mTc-tetrofosmin.
Acquisition on the conventional dual head SPECT camera
was performed using a low-energy high-resolution collimator,
a 20% symmetric window at 140 keV, a 64×64 matrix, and an
elliptical orbit with step-and-shoot acquisition at intervals of 3°
over an arc of 180° (45° anterior oblique to 45° left posterior
oblique) with 30 steps (60 views). Electrocardiogram-gated
scans were acquired using 16 bins. The scan time was set to
25 s per frame for stress and rest, resulting in a total scan time
(including interstep rotation time) of 14 min and 52 s
according to the guidelines [14].
Scans on the CZT camera were acquired using a multipin-
hole collimator (effective diameter aperture 5.1 mm) and
19 stationary detectors simultaneously imaging 19 views
of the heart. Each detector contained 32×32 pixelated
(2.46×2.46 mm) CZT elements. Image acquisition was
performed using list mode. A 10% symmetrical energy
window at 140 keV was used. Electrocardiogram-gated scans
were acquired using 16 bins. Scans on the CZT camera were
acquired over 3 min for stress and 2 min for rest, as recently
established [12, 13]. As the CZT detectors are aligned around
the patient, covering the entire heart, acquisition of all
cardiac views simultaneously is possible, as opposed to the
SPECT acquisition.
The study protocol was approved by the local ethics
committee and written informed consent was obtained from
every patient.
CT attenuation correction
To create CTAC maps all patients underwent an unenhanced
64-slice CT examination on a LightSpeed VCT Scanner (GE
Healthcare) during breath-hold as previously reported [6]. The
scans covered the entire heart using prospectively
electrocardiogram-triggered sequential images at 75% of
the R-R interval, 2.5 mm section thickness, and 0.35 s gantry
rotation time at 120 kV and 200 mA, depending on the
patient’s body mass index (BMI). CT images were recon-
structed with 5 mm thickness using a reconstruction
algorithm with a 512×512 matrix and a field of view of
50×50 cm adapted to the full chest size. The reconstructed
CT images were then transferred to a Xeleris workstation
(GE Healthcare) for AC map creation.
MPI reconstruction
Images from the conventional SPECT camera were recon-
structed with and without CT AC on a dedicated worksta-
tion using a standard iterative reconstruction algorithm with
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ordered subset expectation maximization (OSEM). CZT
images were reconstructed on the same workstation using a
dedicated iterative algorithm with maximum likelihood
expectation maximization (MLEM). Perfusion images in
standard axis (short axis, vertical long axis, horizontal long
axis) and polar maps of the left ventricle were obtained.
Visual analysis
Scans from both conventional SPECT and CZT were
analyzed in consensus by two experienced readers blinded
to any information on patient identification or the camera
utilized or acquisition type. Cardiac perfusion was assessed
on a per patient basis and for each vessel territory with
regard to severity using a five-point scale (1 normal, 2
equivocal, 3 perfusion defect with moderate decrease in
uptake, 4 severe decrease in uptake, 5 absent) and extent
using a three-point scale (1 small, 2 moderate, 3 large), as
previously reported [15]. Agreement and discrepancies in
severity and extent between conventional SPECT with and
without AC and between CZT with and without breath-hold
triggering were recorded per patient and per coronary
territory. The former served as the reference standard, as
CT AC is not yet validated for this novel CZT camera
system. Image quality was assessed subjectively on a four-
point scale (1 poor, 2 fair, 3 good, 4 excellent) with the
following parameters being considered: myocardial count
density and uniformity, endocardial and epicardial edge
definition, and background noise
Quantitative analysis
The software package Myovation for Alcyone (GE Health-
care) was used for quantitative analysis off MPI polar maps
using a 20-segment model for the left ventricle. Uptake was
normalized to 100% peak activity and relative myocardial
uptake (percent of maximum myocardial uptake) was
assessed from the SPECT and CZT data for each vessel
territory: left anterior descending artery (LAD), segments 1,
2, 7, 8, 13, 14, 15, 19 and 20; left circumflex artery (LCX),
segments 5, 6, 11, 12, 17 and 18; right coronary artery
(RCA), segments 3, 4, 9, 10 and 16. Automated analysis of
gated acquisitions from high-dose (rest) scans was per-
formed to determine left ventricular ejection fraction
(LVEF).
Statistics
SPSS 17.0 (SPSS, Chicago, IL) was used for statistical
testing. Quantitative variables are expressed as means±SD
and categorical variables as frequencies or percentages. The
correlation of tracer uptake and LVEF between AC SPECT
and CZT with and without breath-hold triggering was
evaluated using intraclass correlation analysis (absolute
agreement) and Fisher’s Z-transformation was used to
compare correlation coefficients. In addition, Bland-
Altman (BA) limits of agreement were calculated. P values
less than 0.05 were considered statistically significant and
the 95% confidence intervals are presented.
Results
Patient characteristics are given in Table 1. Patients were
referred for nuclear MPI for the following reasons:
suspected CAD (n=25, 62%), follow-up of a known CAD
(n=14, 35%), preoperative risk assessment before major
noncardiac surgery (n=1, 3%). In 39 patients (97%)
pharmacological stress was induced with adenosine and in
1 patient (3%) with dobutamine. For stress and rest, mean
doses of 327±25 MBq (range 292–414 MBq) and 940
±47 MBq (range 900–1180 MBq) 99mTc-tetrofosmin were
administered, respectively. All 40 patients underwent MPI
on both cameras and real-time breath-hold triggering was
successfully performed in all patients.
Visual analysis
The quality of conventional SPECT MPI scans without AC
was good or excellent in 36 patients (90%) and fair in 4
patients (10%). After AC, the quality of SPECT MPI scans
was good or excellent in 37 patients (93%) and fair in 3
patients (7%). The quality of CZT scans without breath-
hold triggering was good or excellent in 35 patients (87%),
fair in 4 patients (10%), and poor in 1 patient (3%). The
quality of CZT scans with breath-hold triggering was good
or excellent in 39 patients (97%) and fair in 1 patient (3%).
Gastrointestinal tracer activity adjacent to the myocardial
wall was seen in both SPECT and CZT scans in nine
patients.
Uncorrected SPECT scans showed 19 apparent perfusion
defects that were identified as artefacts after applying AC,
predominantly located in the RCA territory (Fig. 1a). All 19
artefacts were also seen in the nontriggered CZT scans.
With breath-hold triggering 13 apparent perfusion defects
were identified as artefacts and 4 were at least partially
unmasked as they were substantially decreased in extent
and/or severity. One additional apparent perfusion defect,
present on CZT scans but not on SPECT MPI scans, was
appropriately identified as an artefact by breath-hold
triggering. The latter was most successful in the RCA
territory (Fig. 1b).
True myocardial perfusion defects were revealed in 16
AC SPECT MPI scans (5 fixed and 6 reversible defects) in
11 patients. All corresponding defects were equally identi-
fied by CZT scans with and without breath-hold triggering,
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indicating that the gain in specificity (i.e. the unmasking of
apparent defects as artefacts) was not achieved at the cost of
a decrease in sensitivity. Of note, five apparent defects in
the RCA territory confirmed as true defects by CT AC
SPECT were also identified by CZT with and without
breath-hold triggering, indicating specifically in this terri-
tory, which is most prone to artefacts, that the corrections
were not over-corrections. Figure 2 illustrates the impact of
AC and breath-hold triggering on artefacts in SPECT MPI
and CZT MPI, respectively.
Quantitative analysis
The intraclass correlation coefficient (r) comparing myo-
cardial tracer uptake between conventional AC SPECT MPI
and CZT without breath-hold triggering was 0.81 (95% CI
0.63–0.88, p<0.001) and between conventional AC SPECT
MPI and CZT with breath-hold triggering was significantly
better (p<0.001) at 0.90 (95% CI 0.85–0.93, p<0.001).
Consequently, when comparing CZT to conventional AC
SPECT scans, the BA limits of agreement for percent
myocardial tracer uptake narrowed from −17% to 9% for
CZT without breath-hold triggering to −12% to 8% for CZT
with breath-hold triggering.
The intraclass correlation coefficient comparing LVEF
between SPECT and CZT without breath-hold triggering
was 0.92 (95% CI 0.84–0.96, p<0.001) and the BA limits
of agreement were −17% to 12%. The correlation coeffi-
cient for the comparison between SPECT and CZT with
breath-hold triggering was the same at 0.93 (95% CI 0.80–
0.97, p<0.001) and the BA limits of agreement were −16%
to 8% for CZT with breath-hold triggering.
Discussion
The finding of apparent perfusion defects that are in fact
artefacts due to tissue attenuation and/or gastrointestinal tracer
activity is not uncommon in MPI but may be overcome by
appropriate AC. In the present study AC identified 19 such
apparent perfusion defects on SPECT MPI as artefacts.
Similarly, breath-hold triggering identified 13 of these
apparent perfusion defects on the CZT scans as artefacts,
and additionally led to a partial unmasking of four of the
remaining six artefacts by substantially decreasing the extent
Table 1 Patient baseline characteristics (n=40)
Male 24 (60%)
Age (years)
Mean±SD 66±10
Range 43–81
BMI (kg/m2)
Mean±SD 26±4
Range 19–34
Cardiovascular risk factors
Obesity (BMI >30 kg/m2) 7 (18%)
Smoking 9 (23%)
Diabetes mellitus 7 (18%)
Hypertension 27 (68%)
Dyslipidaemia 20 (50%)
Positive family history 5 (13%)
Clinical symptoms
Typical angina pectoris 2 (5%)
Atypical chest pain 21 (53%)
Dyspnoea 3 (8%)
No cardiac symptoms 14 (35%)
Current cardiac medication
Aspirin 21 (53%)
Beta-blocker 16 (40%)
ACE/angiotensin-II Inhibitor 17 (43%)
Statin 21 (53%)
Fig. 1 Artefacts (as determined
by AC SPECT MPI) were
predominantly present in the
RCA territory (a). Breath-hold
triggering proved most success-
ful in identifying artefacts in the
RCA territory (b). (* LAD vs.
LCX, non significant; † LAD
vs. RCA, p<0.05; ‡ LCX vs.
RCA, p<0.05)
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and/or severity of the apparent perfusion defect. Breath-hold
triggering was most effective in patients with subdiaphrag-
matic tracer activity and in obese patients with attenuation
artefacts in the RCA territory, where most of the artefacts
where located (Fig. 1). Conversely, in the present study, CZT
scans with breath-hold triggering correctly identified all
perfusion defects that were confirmed as true defects by AC.
Thus, applying breath-hold triggering successfully increased
the specificity for discriminating true defects from artefacts
without affecting sensitivity to detect defects.
Several different approaches have been described to
improve reader confidence in SPECT MPI by identifying
apparent defects as artefacts caused by tissue attenuation or
subdiaphragmatic tracer activity. Among these, the most
efficient and accurate technique is AC based on transmission
data obtained either by an additional rotating isotope or by CT
[14]. However, on the other hand AC can potentially
introduce artefacts, particularly in the presence of subdiaph-
ragmatic tracer activity [16]. Similarly, scanning in the prone
position to correct for inferior attenuation has been associated
with artefacts that are interpreted as anteroseptal defects [3].
Consequently, even when applying any of the above
procedures for AC, image interpretation should still integrate
all available patient information, including obesity and gender,
as well as wall motion analysis from electrocardiogram-gated
SPECT [4, 17], as this increases accuracy and reader
confidence as to whether an apparent defect should be
classified as a true defect or as an artefact. The present study
demonstrated that real-time breath-hold triggering confining
the image acquisition to breath-hold at deep inspiration levels
may serve as an alternative to CT AC, as it unmasked the
majority of artefacts. This was particularly successful in the
RCA territory (79% of artefacts unmasked, Fig. 1b) where
most of the attenuation artefacts were found, in line with a
large body of literature (Fig. 1a) [14].
The concept of breath-hold gating is not new [7–11].
However, most previous studies have focused on retrospec-
tive respiratory gating using rotating dual head SPECT
gamma cameras requiring either an increase in activity or a
prolongation of the acquisition time, rendering the proce-
dure very cumbersome. In addition, retrospective gating
does not allow scanning at forced inspiration as such
controlled breathing is not feasible over a prolonged period
of 20 to 30 minutes. These drawbacks have so far hampered
the introduction of respiratory gating for SPECT MPI into
daily clinical routine. By contrast, this present study
validated the use of real-time breath-hold triggering with
breath hold at maximal inspiration, overcoming the above
drawbacks and potentially paving the way for its introduc-
tion into clinical use.
Fig. 2 SPECT MPI image
without AC (a) and CZT MPI
image without breath-hold
triggering (b) show an apparent
inferior perfusion defect which
was identified as an artefact
as it is not present on the
SPECT MPI image after AC
(c) or on the CZT MPI image
after breath-hold triggering (d)
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Attenuation artefacts have for a long time been known to
affect the specificity of nuclear MPI. Although recently
low-dose CT has emerged as an excellent tool for accurate
AC [6], the need for an integrated SPECT/CT device with
higher costs or time-consuming repositioning of the patient
into a stand-alone CT scanner have limited its widespread
use. Similarly, the vast majority of latest generation gamma
cameras with CZT detectors will not be equipped with a CT
facility. Therefore, real-time CZT MPI with breath-hold
triggering offers a welcome alternative to CT AC for
discriminating artefacts from true perfusion defects.
It may be perceived as a limitation of this study that we
did not use invasive coronary angiography as the reference
standard. However, this study was aimed at evaluating the
impact of real-time breath-hold triggering on MPI. We felt
that it was sufficient to use a reference image modality
directly reflecting myocardial perfusion, while invasive
coronary angiography would have been a flawed reference
standard as anatomical findings do not necessarily reflect
the underlying haemodynamic situation. The use of any
other non-SPECT MPI such as MRI or PET would have
involved many technical differences and would have
required complex protocols with coinjection of the respec-
tive flow tracer. Therefore, we used CT AC SPECT as the
reference standard, as CT-based AC for SPECT has been
shown to improve accuracy [18]. Finally, breath holding
may potentially pose a problem in patients with dyspnoea.
However, the advantage of the present protocol is that, in
contrast to breath holding for CT scanning, the duration of
the breath hold can be dictated by the patient’s ability. This
may have positively influenced patient comfort.
Conclusion
We have established a protocol for real-time breath-hold
triggering of MPI on a novel CZT gamma camera as a
potential alternative to AC to assist in the discrimination of
artefacts caused by soft-tissue attenuation or subdiaphrag-
matic tracer activity from true perfusion defects.
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